Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women

OBJECTIVES: To clarify potential differences between denosumab (DNS) and bisphosphonates (BIS) in terms of bone density and bone metabolism, in a sample of postmenopausal women. METHODS: A total of 113 postmenopausal women aged 53-66 years were treated with either DNS or BIS for 12 months. Bone dens...

Descripción completa

Detalles Bibliográficos
Autores principales: Augoulea, A., Tsakonas, E., Triantafyllopoulos, I., Rizos, D., Armeni, E., Tsoltos, N., Tournis, S., Deligeoroglou, E., Antoniou, A., Lambrinoudaki, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383772/
https://www.ncbi.nlm.nih.gov/pubmed/28250248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383772/
https://www.ncbi.nlm.nih.gov/pubmed/28250248

Ejemplares similares